re:tides oligonucleotide & peptide therapeutic, page-24

So far my relationship with the company has been excellent. They have respected my desire NOT to have access to any information that I shouldn't know (naturally that is their policy as well) so I won't be compromised here or in any market transactions.

I have the same access as any others it seems and hear the same information as everyone else. If I had access to anything I shouldn't - you are correct in saying I wouldn't be sharing it here - or with anyone.

I hope the PYC share price eventually treats me like ADO and a few others have but I am a realist - this stock is more likely to fail than ADO and also more likely to return a larger % return than ADO.

I believe the fair value for what they have achieved to date is considerably above the current MCAP of $16m and could understand a valuation of 30-50m and maybe even up to $100m given 30% of the shares are locked up in 2 holders hands but there has been a poor track record for investors so I also understand why no one is watching till some news worth talking about occurs.

Flow wise I imagine there might be some who exit (maybe already have?) and offset capital losses and then July might get interesting again but a creep back to 2-3c is pretty likely IMHO.